The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Machine learning in preclinical drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Evolutionary-scale prediction of atomic level protein structure with a language model
Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., Shmueli, Y., et al. (2022) · doi:10.1101/2022.07.20.500902 · Cited by 5,990
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Self-citationWatson, J. L., Juergens, D., Bennett, N. R., Trippe, B. L., Yim, J., Eisenach, H. E., Ahern, W., Borst, A. J., Ragotte, R. J., Milles, L. F., et al. (2022) · doi:10.1101/2022.12.09.519842 · Cited by 2,369
De novo design of protein structure and function with RFdiffusion
Watson, J. L., Juergens, D., Bennett, N. R., Trippe, B. L., Yim, J., Eisenach, H. E., Ahern, W., Borst, A. J., Ragotte, R. J., Milles, L. F., et al. (2023) · Nature · doi:10.1038/s41586-023-06415-8 · Cited by 2,325
UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches
Suzek, B. E., Wang, Y., Huang, H., McGarvey, P. B., Wu, C. H., & the UniProt Consortium (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu739 · Cited by 1,928
Analyzing Learned Molecular Representations for Property Prediction
Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00237 · Cited by 1,923
Why 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Wouters, O. J., McKee, M., & Luyten, J. (2020) · JAMA · doi:10.1001/jama.2020.1166 · Cited by 1,531
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Transfer learning enables predictions in network biology
Theodoris, C. V., Xiao, L., Chopra, A., Chaffin, M. D., Al Sayed, Z. R., Hill, M. C., Mantineo, H., Brydon, E. M., Zeng, Z., Liu, X. S., et al. (2023) · Nature · doi:10.1038/s41586-023-06139-9 · Cited by 1,193
Large language models generate functional protein sequences across diverse families
Madani, A., Krause, B., Greene, E. R., Subramanian, S., Mohr, B. P., Holton, J. M., Olmos, J. L., Xiong, C., Sun, Z. Z., Socher, R., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01618-2 · Cited by 1,078 · cited 1×
“Protein language models (PLMs) may overcome this challenge by pretraining transformer-based models on protein sequences, which can learn patterns reflective of evolution while capturing secondary tertiary structures 72,74,75 .”
Autonomous chemical research with large language models
Boiko, D. A., MacKnight, R., Kline, B., & Gomes, G. (2023) · Nature · doi:10.1038/s41586-023-06792-0 · Cited by 1,050 · cited 1×
“Transformer-based large language models (LLMs) are also being increasingly applied for generative chemistry 57,58 .”
GuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Reymond, J.-L. (2015) · Accounts of Chemical Research · doi:10.1021/ar500432k · Cited by 720 · cited 1×
“For reference, the upper size limit of chemical libraries that can be reasonably virtually screened lies on the order of billions, a number that is dwarfed by drug-like chemical space, which is estimated to be upward of 10 60 molecules 33 .”
Trends in clinical success rates and therapeutic focus
Dowden, H., & Munro, J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00074-z · Cited by 649 · cited 1×
“5,6 .”
Phase II and phase III failures: 2013–2015
Harrison, R. K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.184 · Cited by 636
Yang, F., Wang, W., Wang, F., Fang, Y., Tang, D., Huang, J., Lu, H., & Yao, J. (2021) · doi:10.1101/2021.12.05.471261 · Cited by 617
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578
A practical guide to large-scale docking
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00597-z · Cited by 546 · cited 4×
“%) of molecules from the virtual library and docks them using conventional methods 26–30 .”
InfluentialConvolutional embedding of attributed molecular graphs for physical property prediction
Coley, C. W., Barzilay, R., Green, W. H., Jaakkola, T. S., & Jensen, K. F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00601 · Cited by 470
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
Chaffin, M., Papangeli, I., Simonson, B., Akkad, A.-D., Hill, M. C., Arduini, A., Fleming, S. J., Melanson, M., Hayat, S., Kost-Alimova, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04817-8 · Cited by 418
Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00659-2 · Cited by 397 · cited 1×
“For instance, property labels that are used to train the model are generated using in silico docking algorithms, which come with varying levels of accuracy based on the structure of the ligand and protein as well as the parametrization of the docking software 27,28 .”
High-resolution de novo structure prediction from primary sequence
Wu, R., Ding, F., Wang, R., Shen, R., Zhang, X., Luo, S., Su, C., Wu, Z., Xie, Q., Berger, B., et al. (2022) · doi:10.1101/2022.07.21.500999 · Cited by 392 · cited 4×
“These representations are inputted into GeoFormer, a geometry-inspired transformer, to learn consistent structural and physical relationships between amino acids when projected into 3D space 73 .”
InfluentialLeveraging large language models for predictive chemistry
Jablonka, K. M., Schwaller, P., Ortega-Guerrero, A., & Smit, B. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-023-00788-1 · Cited by 378
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Ren, F., Ding, X., Zheng, M., Korzinkin, M., Cai, X., Zhu, W., Mantsyzov, A., Aliper, A., Aladinskiy, V., Cao, Z., et al. (2023) · Chemical Science · doi:10.1039/d2sc05709c · Cited by 365
ZINC-22─A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery
Tingle, B. I., Tang, K. G., Castanon, M., Gutierrez, J. J., Khurelbaatar, M., Dandarchuluun, C., Moroz, Y. S., & Irwin, J. J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01253 · Cited by 314
Trends in clinical success rates
Smietana, K., Siatkowski, M., & Møller, M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.85 · Cited by 277 · cited 1×
“However, this traditional approach is associated with a roughly 90% failure rate for candidate compounds traversing from phase 1 clinical trials to market approval, with a much higher rate when accounting for the preclinical stages of discovery 4 .”
Assessing the impact of generative AI on medicinal chemistry
Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
Ivanenkov, Y. A., Polykovskiy, D., Bezrukov, D., Zagribelnyy, B., Aladinskiy, V., Kamya, P., Aliper, A., Ren, F., & Zhavoronkov, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01191 · Cited by 231
A critical overview of computational approaches employed for COVID-19 drug discovery
Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01065k · Cited by 206
Goldberg, S. B., Flemotomos, N., Martinez, V. R., Tanana, M. J., Kuo, P. B., Pace, B. T., Villatte, J. L., Georgiou, P. G., Van Epps, J., Imel, Z. E., et al. (2020) · Journal of Counseling Psychology · doi:10.1037/cou0000382 · Cited by 141
Neural scaling of deep chemical models
Frey, N. C., Soklaski, R., Axelrod, S., Samsi, S., Gómez-Bombarelli, R., Coley, C. W., & Gadepally, V. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00740-3 · Cited by 125
Ackloo, S., Al-awar, R., Amaro, R. E., Arrowsmith, C. H., Azevedo, H., Batey, R. A., Bengio, Y., Betz, U. A. K., Bologa, C. G., Chodera, J. D., et al. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00363-z · Cited by 112
Emergent autonomous scientific research capabilities of large language models
Boiko, D. A., MacKnight, R., & Gomes, G. (2023) · arXiv · doi:10.48550/arxiv.2304.05332 · Cited by 72
Research works printed but not linked: 71
- Schenone, M., Dančík, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232–240 (2013). · DOI · Paper page
- Ashenden, S. K. in The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry Ch. 6 (Elsevier, 2021). · DOI
- Janai, J., Güney, F., Behl, A. & Geiger, A. Computer vision for autonomous vehicles: problems, datasets and state of the art. Found. Trends Comp. Graph. Vis. 12, 1–308 (2020).
- Peterson, A. A. & Liu, D. R. Small-molecule discovery through DNA-encoded libraries. Nat. Rev. Drug Discov. 22, 699–722 (2023). · DOI · Paper page
- Lim, K. S. et al. Machine learning on DNA-encoded library count data using an uncertainty-aware probabilistic loss function. J. Chem. Inf. Model. 62, 2316–2331 (2022). · DOI
- Hou, R., Xie, C., Gui, Y., Li, G. & Li, X. Machine-learning-based data analysis method for cell-based selection of DNA-encoded libraries. ACS Omega 8, 19057–19071 (2023). · DOI
- Van de Sande, B. et al. Applications of single-cell RNA sequencing in drug discovery and development. Nat. Rev. Drug Discov. 22, 496–520 (2023). · DOI · Paper page
- Chen, J. et al. Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data. Nat. Commun. 13, 6494 (2022). · DOI · Paper page
- Godinez, W. J., Hossain, I., Lazic, S. E., Davies, J. W. & Zhang, X. A multi-scale convolutional neural network for phenotyping high-content cellular images. Bioinformatics 33, 2010–2019 (2017). · DOI · Paper page
- Jin, W. et al. Deep learning identifies synergistic drug combinations for treating COVID-19. Proc. Natl Acad. Sci. USA 118, e2105070118 (2021). · DOI · Paper page
- Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742–754 (2010). · DOI · Paper page
- Fernández-De Gortari, E., García-Jacas, C. R., Martinez-Mayorga, K. & Medina-Franco, J. L. Database fingerprint (DFP): an approach to represent molecular databases. J. Cheminform. 9, 9 (2017).
- Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. https://doi.org/10.1038/s41589-023-01349-8 (2023). · DOI · Paper page
- Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med. 23, 405–408 (2017). · DOI · Paper page
- Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177–185 (2024). · DOI · Paper page
- Tropsha, A., Isayev, O., Varnek, A., Schneider, G. & Cherkasov, A. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat. Rev. Drug Discov. 23, 141–155 (2024). · DOI · Paper page
- Rossetti, G. G. et al. Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci. Rep. 12, 2505 (2022). · DOI
- Anstine, D. M. & Isayev, O. Generative models as an emerging paradigm in the chemical sciences. J. Am. Chem. Soc. 145, 8736–8750 (2023). · DOI · Paper page
- Jin, W., Barzilay, R. & Jaakkola, T. Junction tree variational autoencoder for molecular graph generation. Preprint at arxiv.org/abs/1802.04364 (2018). · arXiv
- Godinez, W. J. et al. Design of potent antimalarials with generative chemistry. Nat. Mach. Intell. 4, 180–186 (2022). · DOI
- Cesaro, A., Bagheri, M., Torres, M., Wan, F. & de la Fuente-Nunez, C. Deep learning tools to accelerate antibiotic discovery. Expert Opin. Drug Discov. 18, 1245–1257 (2023). · DOI
- Rezende, D. J. & Mohamed, S. Variational inference with normalizing flows. In Proc. 32nd International Conference on Machine Learning 2, 1530–1538 (PMLR, 2015).
- Shekhovtsov, A., Schlesinger, D. & Flach, B. VAE approximation error: ELBO and exponential families. Preprint at arxiv.org/abs/2102.09310 (2021). · arXiv
- Shi, C. et al. GraphAF: a flow-based autoregressive model for molecular graph generation. Preprint at arxiv.org/abs/2001.09382 (2020). · arXiv
- Hoogeboom, E., Satorras, V. G., Vignac, C. & Welling, M. Equivariant diffusion for molecule generation in 3D. In Proc. 39th International Conference on Machine Learning 8867–8887 (2022).
- Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 28, 31–36 (1988).
- Grisoni, F. Chemical language models for de novo drug design: challenges and opportunities. Curr. Opin. Struct. Biol. 79, 102527 (2023). · DOI
- Flam-Shepherd, D., Zhu, K. & Aspuru-Guzik, A. Language models can learn complex molecular distributions. Nat. Commun. 13, 3293 (2022). · DOI · Paper page
- Skinnider, M. A., Greg Stacey, R., Wishart, D. S. & Foster, L. J. Chemical language models enable navigation in sparsely populated chemical space. Nat. Mach. Intell. 3, 759–770 (2021). · DOI · Paper page
- Moret, M., Friedrich, L., Grisoni, F., Merk, D. & Schneider, G. Generative molecular design in low data regimes. Commun. Chem. 5, 129 (2022). · DOI
- Ballarotto, M. et al. De novo design of Nurr1 agonists via fragment-augmented generative deep learning in low-data regime. J. Med. Chem. 66, 8170–8177 (2023). · DOI
- Moret, M. et al. Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nat. Commun. 14, 114 (2023). · DOI · Paper page
- Grisoni, F. et al. Combining generative artificial intelligence and on-chip synthesis for de novo drug design. Sci. Adv. 7, 3338–3349 (2021). · DOI · Paper page
- Vaswani, A. et al. Attention is all you need. Preprint at arxiv.org/abs/1706.03762 (2023). · arXiv
- Bagal, V., Aggarwal, R., Vinod, P. K. & Priyakumar, U. D. MolGPT: molecular generation using a transformer-decoder model. J. Chem. Inf. Model. 62, 2064–2076 (2021). · DOI · Paper page
- Born, J. & Manica, M. Regression Transformer enables concurrent sequence regression and generation for molecular language modelling. Nat. Mach. Intell. 5, 432–444 (2023). · DOI
- Grechishnikova, D. Transformer neural network for protein-specific de novo drug generation as a machine translation problem. Sci. Rep. 11, 321 (2021). · DOI · Paper page
- Stsiapanava, A. et al. Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH. Nat. Struct. Mol. Biol. 29, 190–193 (2022). · DOI
- Liu, H. et al. Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles. Sci. Adv. 8, eabo4184 (2022). · DOI
- Yang, Q. et al. Structural comparison and drug screening of spike proteins of ten SARS-CoV-2 variants. Research 2022, 9781758 (2022).
- Yang, Q., Xia, D., Syed, A. A. S., Wang, Z. & Shi, Y. Highly accurate protein structure prediction and drug screen of monkeypox virus proteome. J. Infect. 86, 66–117 (2023). · DOI
- Berman, H. M. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000). · DOI · Paper page
- Michaud, J. M., Madani, A. & Fraser, J. S. A language model beats AlphaFold2 on orphans. Nat. Biotechnol. 40, 1576–1577 (2022). · DOI
- Fang, X. et al. A method for multiple-sequence-alignment-free protein structure prediction using a protein language model. Nat. Mach. Intell. 5, 1087–1096 (2023). · DOI · Paper page
- Corso, G., Stärk, H., Barzilay, R. & Jaakkola, T. DiffDock: diffusion steps, twists, and turns for molecular docking. Preprint at arxiv.org/abs/2210.01776 (2022). · arXiv
- Goodnow, R. A. Hit and lead identification: integrated technology-based approaches. Drug Discov. Today Technol. 3, 367–375 (2006). · DOI
- Yang, L. et al. Transformer-based deep learning method for optimizing ADMET properties of lead compounds. Phys. Chem. Chem. Phys. 25, 2377–2385 (2023).
- Chen, Y., Yu, X., Li, W., Tang, Y. & Liu, G. In silico prediction of hERG blockers using machine learning and deep learning approaches. J. Appl. Toxicol. 43, 1462–1475 (2023). · DOI
- Sharma, B. et al. Accurate clinical toxicity prediction using multi-task deep neural nets and contrastive molecular explanations. Sci. Rep. 13, 4908 (2023). · DOI
- Lipinski, C. A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1, 337–341 (2004). · DOI · Paper page
- Coutinho, A. L. et al. A robust, viable, and resource sparing HPLC-based log P method applied to common drugs. Int. J. Pharm. 644, 123325 (2023). · doi:10.1016/j.ijpharm.2023.123325
- Faller, B. & Ertl, P. Computational approaches to determine drug solubility. Adv. Drug Deliv. Rev. 59, 533–545 (2007). · DOI · Paper page
- Aliagas, I., Gobbi, A., Lee, M. L. & Sellers, B. D. Comparison of log P and log D correction models trained with public and proprietary data sets. J. Comput. Aided Mol. Des. 36, 253–262 (2022). · doi:10.1007/s10822-022-00450-9
- Win, Z. M., Cheong, A. M. Y. & Hopkins, W. S. Using machine learning to predict partition coefficient (log P) and distribution coefficient (log D) with molecular descriptors and liquid chromatography retention time. J. Chem. Inf. Model. 63, 1906–1913 (2023). · DOI
- Domingo-Almenara, X. et al. The METLIN small molecule dataset for machine learning-based retention time prediction. Nat. Commun. 10, 5811 (2019). · DOI · Paper page
- Datta, R., Das, D. & Das, S. Efficient lipophilicity prediction of molecules employing deep-learning models. Chemometr. Intell. Lab. Syst. 213, 104309 (2021). · DOI
- Prasad, S. & Brooks, B. R. A deep learning approach for the blind log P prediction in SAMPL6 challenge. J. Comput. Aided Mol. Des. 34, 535–542 (2020). · DOI
- Heijman, J., Voigt, N., Carlsson, L. G. & Dobrev, D. Cardiac safety assays. Curr. Opin. Pharmacol. 15, 16–21 (2014). · DOI
- Huang, R. et al. Tox21Challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental chemicals and drugs. Front. Environ. Sci. https://doi.org/10.3389/fenvs.2015.00085 (2016). · DOI · Paper page
- Ramakrishnan, R., Dral, P. O., Rupp, M. & von Lilienfeld, O. A. Quantum chemistry structures and properties of 134 kilo molecules. Sci. Data 1, 140022 (2014).
- Frye, L., Bhat, S., Akinsanya, K. & Abel, R. From computer-aided drug discovery to computer-driven drug discovery. Drug Discov. Today Technol. 39, 111–117 (2021). · DOI
- Zeng, W., Guo, L., Xu, S., Chen, J. & Zhou, J. High-throughput screening technology in industrial biotechnology. Trends Biotechnol. 38, 888–906 (2020). · DOI · Paper page
- Sarkar, N. & Stokes, J. M. Practical applications of machine learning for anti-infective drug discovery. Med. Chem. Rev. 14, 345–375 (2023). · DOI
- Arnold, A., Alexander, J., Liu, G. & Stokes, J. M. Applications of machine learning in microbial natural product drug discovery. Expert Opin. Drug Discov. 18, 1259–1272 (2023). · DOI
- Mullowney, M. W. et al. Artificial intelligence for natural product drug discovery. Nat. Rev. Drug Discov. 22, 895–916 (2023). · DOI · Paper page
- Grisoni, F. et al. Designing anticancer peptides by constructive machine learning. ChemMedChem 13, 1300–1302 (2018). · DOI · Paper page
- Chen, J., Cheong, H. H. & Siu, S. W. I. xDeep-AcPEP: deep learning method for anticancer peptide activity prediction based on convolutional neural network and multitask learning. J. Chem. Inf. Model. 61, 3789–3803 (2021). · DOI
- Walker, A. S. & Clardy, J. A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters. J. Chem. Inf. Model. 61, 2560–2571 (2021). · DOI
- Wellawatte, G. P., Gandhi, H. A., Seshadri, A. & White, A. D. A perspective on explanations of molecular prediction models. J. Chem. Theory Comput. 19, 2149–2160 (2023). · DOI
- Cichońska, A. et al. Crowdsourced mapping of unexplored target space of kinase inhibitors. Nat. Commun. 12, 3307 (2021). · DOI
- Ketkar, N. in Deep Learning with Python 97–111 (Apress, 2017). · DOI · Paper page
Cited by
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 498
Hansson, F. G., Madsen, N. G., Hansen, L. G., Jakočiūnas, T., Lengger, B., Keasling, J. D., Jensen, M. K., Acevedo-Rocha, C. G., & Jensen, E. D. (2025) · Nature Communications · doi:10.1038/s41467-025-59418-6 · Cited by 7
Metadata
- Authors
- Catacutan, D. B., Alexander, J., Arnold, A., & Stokes, J. M.
- Venue
- Nature Chemical Biology
- Published
- 2024-07-19
- Volume
- 20
- Issue
- 8
- Pages
- 960-973
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W4400831251
- Cited by
- 204
- References
- 45
- FWCI
- 39.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Funders
- Gouvernement du Canada | Canadian Institutes of Health Research
- The Weston Family Foundation, The David Braley Centre for Antibiotic Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.